GLPG

Galapagos (GLPG)

Galapagos

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:LSE:GLPG

1 2 3 4 5 6 7 8 9 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/02/23	06:01	UK Regulatory	Galapagos announces full year 2023 results and outlook for 2024	LSE:GLPG	Galapagos
2024/02/16	06:01	UK Regulatory	Galapagos presents at EBMT-EHA annual meeting 2024	LSE:GLPG	Galapagos
2024/02/01	06:01	UK Regulatory	Galapagos completes transaction to transfer Jyseleca® business to Alfasigma	LSE:GLPG	Galapagos
2015/05/06	14:31	GlobeNewswire	Galapagos listed 10 years on Euronext Amsterdam and Brussels	LSE:GLPG	Galapagos
2015/05/06	14:31	GlobeNewswire	Galapagos announces launch of proposed global offering	LSE:GLPG	Galapagos
2015/05/02	01:00	GlobeNewswire	BNP Paribas notify of 4.8% shareholding in Galapagos	LSE:GLPG	Galapagos
2015/05/02	01:00	GlobeNewswire	Galapagos creates new warrant plan	LSE:GLPG	Galapagos
2015/04/28	05:00	GlobeNewswire	Filgotinib as monotherapy also hits primary endpoint in DARWIN 2 trial	LSE:GLPG	Galapagos
2015/04/16	06:00	GlobeNewswire	Galapagos files registration statement in the United States for a proposed global offering	LSE:GLPG	Galapagos
2015/04/15	05:00	GlobeNewswire	Galapagos' JAK1 inhibitor filgotinib (GLPG0634) meets primary and other key efficacy endpoints after 12 weeks of treatment in...	LSE:GLPG	Galapagos
2015/03/28	03:29	GlobeNewswire	Publication of Annual Report 2014 and invitation to the Annual Shareholders' Meeting to be held on 28 April 2015	LSE:GLPG	Galapagos
2015/03/27	15:30	GlobeNewswire	Galapagos raises €5.8 million through warrant exercises, Board and Executive Committee members invest	LSE:GLPG	Galapagos
2015/03/17	15:31	GlobeNewswire	Galapagos regains rights to GLPG1690, announces end of alliance with Janssen	LSE:GLPG	Galapagos
2015/03/06	15:35	GlobeNewswire	Galapagos to be included in Amsterdam Midcap Index	LSE:GLPG	Galapagos
2015/03/06	15:31	GlobeNewswire	Galapagos reports 2014 financial results	LSE:GLPG	Galapagos
2015/02/23	15:30	GlobeNewswire	Galapagos reports that the last patient in DARWIN 1 has completed 12 weeks of treatment	LSE:GLPG	Galapagos
2015/02/16	15:30	GlobeNewswire	Galapagos reports positive Phase 1 results for GLPG1690	LSE:GLPG	Galapagos
2015/02/11	15:31	GlobeNewswire	Galapagos receives €1.6 million IWT grant for hepatitis B program	LSE:GLPG	Galapagos
2015/02/09	15:31	GlobeNewswire	BNP Paribas notify of 5.08% shareholding in Galapagos	LSE:GLPG	Galapagos
2015/01/22	15:31	GlobeNewswire	Galapagos receives €2.5 million IWT grant for antibiotic research	LSE:GLPG	Galapagos
2015/01/22	02:56	GlobeNewswire	Delta Lloyd notify of 4.96% shareholding in Galapagos	LSE:GLPG	Galapagos
2015/01/09	15:30	GlobeNewswire	Vicki Sato resigns from Galapagos Board	LSE:GLPG	Galapagos
2015/01/08	15:30	GlobeNewswire	Galapagos starts Phase 2 trial with GLPG1205 in ulcerative colitis patients	LSE:GLPG	Galapagos
2014/12/19	15:31	GlobeNewswire	Galapagos initiates first Phase 1 study in cystic fibrosis and will receive milestone payment from AbbVie	LSE:GLPG	Galapagos
2014/12/16	15:32	GlobeNewswire	Galapagos regains full rights to GPR84 inhibitor GLPG1205	LSE:GLPG	Galapagos
2014/12/12	15:31	GlobeNewswire	Galapagos selects second component of its investigational cystic fibrosis combination treatment	LSE:GLPG	Galapagos
2014/08/08	14:30	GlobeNewswire	Galapagos cash position of €232 M provides solid basis for R&D pipeline investment	LSE:GLPG	Galapagos
2014/08/05	14:31	GlobeNewswire	Galapagos receives milestone in osteoarthritis alliance with Servier	LSE:GLPG	Galapagos
2014/07/26	01:00	GlobeNewswire	Galapagos creates new warrant plan	LSE:GLPG	Galapagos
2014/07/23	14:30	GlobeNewswire	MorphoSys and Galapagos Advance Joint Antibody Program in Inflammatory Diseases into Preclinical Development	LSE:GLPG	Galapagos